Literature DB >> 2124774

Fibrodysplasia ossificans progressiva. An 11-year-old boy treated with a diphosphonate.

L Bruni1, P Giammaria, M C Tozzi, D Camparcola, F Scopinaro, C Imperato.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a severe, rare, autosomal dominant, ectopic ossifying condition, with primary involvement of the skeletal muscles associated with skeletal abnormalities. This report concerns an 11-year-old boy suffering from FOP, who presented significant modification of the musculoskeletal structure of the thorax and problems with articular movements. The patient showed progress after treatment with ethane-1-hydroxy-1,1-diphosphonate (EHDP). In fact, using a scintiscanner we were able to observe a significant improvement in symptoms and a recovery of some of the active sites of ossification.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124774     DOI: 10.1111/j.1651-2227.1990.tb11371.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  4 in total

1.  An unusual cause of pulmonary hypertension and right heart failure.

Authors:  S Orme; J C Underwood; E McCloskey; T J Hendra
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

Review 2.  Fibrodysplasia ossificans progressiva: still turning into wood after 300 years?

Authors:  G Buyse; J Silberstein; N Goemans; P Casaer
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

3.  Chronic intoxication by ethane-1-hydroxy-1,1-diphosphonate (EHDP) in a child with myositis ossificans progressiva.

Authors:  U E Pazzaglia; G Beluffi; A Ravelli; G Zatti; A Martini
Journal:  Pediatr Radiol       Date:  1993

4.  The Diversity of the Clinical Phenotypes in Patients With Fibrodysplasia Ossificans Progressiva.

Authors:  Ali Al Kaissi; Vladimir Kenis; Maher Ben Ghachem; Jochen Hofstaetter; Franz Grill; Rudolf Ganger; Susanne Gerit Kircher
Journal:  J Clin Med Res       Date:  2016-01-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.